Total Payments
$37,719
2024 Payments
$233.22
Companies
22
Transactions
189
Medicare Patients
3,704
Medicare Billing
$279,387
Payment Breakdown by Category
Consulting$29,635 (78.6%)
Travel$4,590 (12.2%)
Food & Beverage$3,494 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $29,635 | 18 | 78.6% |
| Travel and Lodging | $4,590 | 21 | 12.2% |
| Food and Beverage | $3,494 | 150 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $19,191 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $7,173 | 33 | $0 (2023) |
| Midmark Corporation | $4,278 | 7 | $0 (2020) |
| Mylan Specialty L.P. | $2,802 | 6 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $2,800 | 1 | $0 (2020) |
| Lilly USA, LLC | $361.51 | 24 | $0 (2024) |
| Novo Nordisk Inc | $165.30 | 11 | $0 (2023) |
| Merck Sharp & Dohme LLC | $157.01 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $118.33 | 8 | $0 (2022) |
| SANOFI PASTEUR INC. | $114.08 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $233.22 | 13 | Otsuka America Pharmaceutical, Inc. ($79.35) |
| 2023 | $4,413 | 24 | AstraZeneca Pharmaceuticals LP ($4,177) |
| 2022 | $3,068 | 23 | AstraZeneca Pharmaceuticals LP ($2,725) |
| 2021 | $282.46 | 19 | Lilly USA, LLC ($62.92) |
| 2020 | $3,627 | 16 | Teva Pharmaceuticals USA, Inc. ($2,800) |
| 2019 | $8,658 | 24 | GlaxoSmithKline, LLC. ($4,881) |
| 2018 | $17,172 | 52 | GlaxoSmithKline, LLC. ($14,187) |
| 2017 | $265.86 | 18 | GlaxoSmithKline, LLC. ($70.43) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Oncology | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: VACCINE | ||||||
| 04/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Oncology | ||||||
| 03/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes | ||||||
| 12/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PSYCHIATRY | ||||||
| 09/29/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.19 | General |
| 08/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Oncology | ||||||
| 07/24/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,152.00 | General |
| 07/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 06/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Diabetes | ||||||
| 06/29/2023 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,371 | 1,814 | $191,845 | $104,511 |
| 2022 | 24 | 1,117 | 1,472 | $141,289 | $89,575 |
| 2021 | 22 | 761 | 1,011 | $99,570 | $55,862 |
| 2020 | 12 | 455 | 666 | $53,983 | $29,440 |
Total Patients
3,704
Total Services
4,963
Medicare Billing
$279,387
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 490 | $88,236 | $40,571 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 238 | 238 | $38,556 | $30,947 | 80.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 88 | 88 | $6,595 | $6,326 | 95.9% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 22 | 22 | $6,344 | $5,308 | 83.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $20,852 | $3,253 | 15.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 235 | 339 | $3,475 | $2,840 | 81.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $3,696 | $2,644 | 71.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 86 | 86 | $2,580 | $2,528 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 45 | $6,291 | $2,331 | 37.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $1,641 | $1,439 | 87.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $1,230 | $1,205 | 98.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 13 | 14 | $2,170 | $1,145 | 52.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 21 | 25 | $2,300 | $1,073 | 46.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 21 | $3,325 | $889.01 | 26.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 70 | $1,050 | $656.88 | 62.6% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 11 | 12 | $480.00 | $338.04 | 70.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 41 | 51 | $688.50 | $200.94 | 29.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 17 | $935.00 | $189.17 | 20.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 12 | $252.00 | $177.84 | 70.6% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 21 | 21 | $189.00 | $118.86 | 62.9% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 21 | 21 | $168.00 | $106.68 | 63.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 14 | 14 | $336.00 | $104.94 | 31.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 30 | 123 | $399.75 | $80.00 | 20.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 11 | $55.00 | $37.51 | 68.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 363 | $55,518 | $31,729 | 57.2% |
About Dr. Charles Gerk, M.D
Dr. Charles Gerk, M.D is a Family Medicine healthcare provider based in Sterling, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1194992768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Gerk, M.D has received a total of $37,719 in payments from pharmaceutical and medical device companies, with $233.22 received in 2024. These payments were reported across 189 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($29,635).
As a Medicare-enrolled provider, Gerk has provided services to 3,704 Medicare beneficiaries, totaling 4,963 services with total Medicare billing of $279,387. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Sterling, CO
- Active Since 05/13/2008
- Last Updated 09/06/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1194992768
Products in Payments
- TRELEGY ELLIPTA (Drug) $4,933
- Yupelri (Drug) $2,802
- BREZTRI (Drug) $2,762
- SHINGRIX (Biological) $1,275
- MOUNJARO (Drug) $169.47
- SYMBICORT (Drug) $139.32
- FARXIGA (Drug) $118.05
- REXULTI (Drug) $107.69
- TRULICITY (Drug) $78.20
- EMGALITY (Drug) $77.82
- GARDASIL 9 (Biological) $73.23
- ADVAIR (Drug) $70.43
- EUCRISA (Drug) $67.81
- Cologuard Collection Kit (Device) $63.79
- Ozempic (Drug) $62.94
- UBRELVY (Drug) $56.92
- VRAYLAR (Drug) $55.66
- MENACTRA (Drug) $51.81
- SOLIQUA (Drug) $46.95
- NURTEC ODT (Drug) $44.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sterling
Peter Toth, M.d, M.D
Family Medicine — Payments: $2.2M
Family Medicine $2.2M
Angel Blazquez, M.d, M.D
Family Medicine — Payments: $14,812
Family Medicine $14,812
Svetlana Nakatis, M.d, M.D
Family Medicine — Payments: $7,951
Family Medicine $7,951
Ralph Leon, Md, MD
Family Medicine — Payments: $7,465
Family Medicine $7,465
Ricardo Ferreira Lopez, Md, MD
Family Medicine — Payments: $6,458
Family Medicine $6,458
Phong Dang, M.d, M.D
Family Medicine — Payments: $4,674
Family Medicine $4,674